Preclinical Characterization of 22-(4′-Pyridinecarbonyl) Jorunnamycin A against Lung Cancer Cell Invasion and Angiogenesis <i>via</i> AKT/mTOR Signaling

Iksen Iksen, Varisa Pongrakhananon|ACS Pharmacology & Translational Science|2023

Cited by 7